rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-6-5
|
pubmed:abstractText |
Graves' hyperthyroidism and antithyroid drugs empty the intrathyroid stores of hormones and iodine. The consequence is rapid 131I turnover and impending failure of radioiodine therapy. Can administration of additional inactive iodide improve 131I kinetics?
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3,3',5-triiodothyronamine,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Iodide Peroxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Iodides,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Thyrotropin,
http://linkedlifedata.com/resource/pubmed/chemical/Thyrotropin,
http://linkedlifedata.com/resource/pubmed/chemical/Triiodothyronine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0029-5566
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-84
|
pubmed:meshHeading |
pubmed-meshheading:17549318-Administration, Oral,
pubmed-meshheading:17549318-Adult,
pubmed-meshheading:17549318-Aged,
pubmed-meshheading:17549318-Antibodies,
pubmed-meshheading:17549318-Combined Modality Therapy,
pubmed-meshheading:17549318-Female,
pubmed-meshheading:17549318-Graves Disease,
pubmed-meshheading:17549318-Humans,
pubmed-meshheading:17549318-Iodide Peroxidase,
pubmed-meshheading:17549318-Iodides,
pubmed-meshheading:17549318-Iodine Radioisotopes,
pubmed-meshheading:17549318-Male,
pubmed-meshheading:17549318-Middle Aged,
pubmed-meshheading:17549318-Receptors, Thyrotropin,
pubmed-meshheading:17549318-Reference Values,
pubmed-meshheading:17549318-Thyrotropin,
pubmed-meshheading:17549318-Triiodothyronine
|
pubmed:year |
2007
|
pubmed:articleTitle |
Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
|
pubmed:affiliation |
Department of Nuclear Medicine, University of Cologne, 50924 Cologne, Germany. markus.dietlein@uni-koeln.de
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|